HS
HighVista Strategies’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.77M | Buy |
484,559
+304,008
| +168% | +$4.25M | 2.49% | 2 |
|
|
2025
Q1 | $2.43M | Buy |
180,551
+25,988
| +17% | +$350K | 0.94% | 21 |
|
|
2024
Q4 | $2.96M | Sell |
154,563
-30,677
| -17% | -$588K | 1.1% | 22 |
|
|
2024
Q3 | $4.21M | Sell |
185,240
-13,244
| -7% | -$301K | 1.45% | 9 |
|
|
2024
Q2 | $2.58M | Hold |
198,484
| – | – | 0.94% | 30 |
|
|
2024
Q1 | $3.48M | Hold |
198,484
| – | – | 1.24% | 23 |
|
|
2023
Q4 | $4.32M | Buy |
198,484
+93,728
| +89% | +$2.04M | 1.57% | 8 |
|
|
2023
Q3 | $1.61M | Sell |
104,756
-4,009
| -4% | -$61.5K | 0.74% | 41 |
|
|
2023
Q2 | $2.59M | Buy |
108,765
+13,856
| +15% | +$330K | 1.18% | 25 |
|
|
2023
Q1 | $2.41M | Sell |
94,909
-5,073
| -5% | -$129K | 1.97% | 17 |
|
|
2022
Q4 | $2.92M | Sell |
99,982
-2,390
| -2% | -$69.8K | 1.73% | 14 |
|
|
2022
Q3 | $2.1M | Buy |
102,372
+57,333
| +127% | +$1.18M | 1.2% | 28 |
|
|
2022
Q2 | $521K | Sell |
45,039
-4,026
| -8% | -$46.6K | 0.31% | 75 |
|
|
2022
Q1 | $907K | Buy |
+49,065
| New | +$907K | 0.58% | 43 |
|